Unknown NA INTERVENTIONAL 1-arm NCT05646004

621 Real World Study

An Open Single-arm Clinical Investigation to Evaluate the Clinical Safety and Effectiveness of 621

Sponsor: Carl Zeiss Meditec AG

Updated 5 times since 2023 Last updated: Jan 9, 2023 Started: Jan 9, 2023 Primary completion: Sep 1, 2024 Completion: Sep 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Senile Cataract, this trial is ongoing. The trial is conducted by Carl Zeiss Meditec AG and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2023 — Feb 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carl Zeiss Meditec AG

Data source: Carl Zeiss Meditec AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Qionghai, China